{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:04:56Z","timestamp":1792757096277,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"DOI":"10.7759\/cureus.78488","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T14:40:16Z","timestamp":1738680016000},"source":"Crossref","is-referenced-by-count":3,"title":["The Role of Artificial Intelligence in the Detection of Cardiac Amyloidosis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Fatima Ibrahim","family":"Abdalla Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozdaher Gaffer","family":"Hussen Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hassan","family":"Awad Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almontasir Belah Alsadig","family":"Abdalwahab Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen Galaleldin","family":"Elnoor Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Elhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadah Ahmed","family":"Osman Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.26599\/1671-5411.2023.05.006","article-title":"Cardiac amyloidosis: state-of-the-art review","volume":"20","author":"Bukhari S","year":"2023","unstructured":"Bukhari S. Cardiac amyloidosis: state-of-the-art review. J Geriatr Cardiol. 2023, 20:361-75. 10.26599\/1671-5411.2023.05.006","journal-title":"J Geriatr Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101366","article-title":"A review of cardiac amyloidosis: presentation, diagnosis, and treatment","volume":"47","author":"Pour-Ghaz I","year":"2022","unstructured":"Pour-Ghaz I, Bath A, Kayali S, et al.. A review of cardiac amyloidosis: presentation, diagnosis, and treatment. Curr Probl Cardiol. 2022, 47:101366. 10.1016\/j.cpcardiol.2022.101366","journal-title":"Curr Probl Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz MA","year":"2015","unstructured":"Gertz MA, Dispenzieri A, Sher T. Pathophysiology and treatment of cardiac amyloidosis. Nat Rev Cardiol. 2015, 12:91-102. 10.1038\/nrcardio.2014.165","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12518","article-title":"Transthyretin cardiac amyloidosis: an update on diagnosis and treatment","volume":"6","author":"Yamamoto H","year":"2019","unstructured":"Yamamoto H, Yokochi T. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Fail. 2019, 6:1128-39. 10.1002\/ehf2.12518","journal-title":"ESC Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/jmai-24-294","article-title":"Role of artificial intelligence in healthcare settings: a systematic review","volume":"8","author":"Ullah W","year":"2025","unstructured":"Ullah W, Ali Q. Role of artificial intelligence in healthcare settings: a systematic review. J Med Artif Intell. 2025, 8:24. 10.21037\/jmai-24-294","journal-title":"J Med Artif Intell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10162-1","article-title":"Epidemiology and clinical manifestations of cardiac amyloidosis","volume":"27","author":"Bajwa F","year":"2022","unstructured":"Bajwa F, O'Connor R, Ananthasubramaniam K. Epidemiology and clinical manifestations of cardiac amyloidosis. Heart Fail Rev. 2022, 27:1471-84. 10.1007\/s10741-021-10162-1","journal-title":"Heart Fail Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2023.02.009","article-title":"Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis","volume":"81","author":"Bukhari S","year":"2023","unstructured":"Bukhari S, Khan B. Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis. J Cardiol. 2023, 81:429-33. 10.1016\/j.jjcc.2023.02.009","journal-title":"J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2023.2267756","article-title":"An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value","volume":"20","author":"Ribeiro HC","year":"2023","unstructured":"Ribeiro HC, Zandonadi FD, Sussulini A. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value. Expert Rev Proteomics. 2023, 20:267-80. 10.1080\/14789450.2023.2267756","journal-title":"Expert Rev Proteomics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg FL","year":"2024","unstructured":"Ruberg FL, Maurer MS. Cardiac amyloidosis due to transthyretin protein: a review. JAMA. 2024, 331:778-91. 10.1001\/jama.2024.0442","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami M","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020, 37:387. 10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms","volume":"12","author":"Goto S","year":"2021","unstructured":"Goto S, Mahara K, Beussink-Nelson L, et al.. Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms. Nat Commun. 2021, 12:2726. 10.1038\/s41467-021-22877-8","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00690-4","article-title":"Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance","volume":"22","author":"Martini N","year":"2020","unstructured":"Martini N, Aimo A, Barison A, et al.. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2020, 22:84. 10.1186\/s12968-020-00690-4","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.04.023","article-title":"Artificial intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis","volume":"96","author":"Grogan M","year":"2021","unstructured":"Grogan M, Lopez-Jimenez F, Cohen-Shelly M, et al.. Artificial intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis. Mayo Clin Proc. 2021, 96:2768-78. 10.1016\/j.mayocp.2021.04.023","journal-title":"Mayo Clin Proc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2023.01.014","article-title":"Deep learning on bone scintigraphy to detect abnormal cardiac uptake at risk of cardiac amyloidosis","volume":"16","author":"Delbarre MA","year":"2023","unstructured":"Delbarre MA, Girardon F, Roquette L, et al.. Deep learning on bone scintigraphy to detect abnormal cardiac uptake at risk of cardiac amyloidosis. JACC Cardiovasc Imaging. 2023, 16:1085-95. 10.1016\/j.jcmg.2023.01.014","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/echo.15516","article-title":"Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis","volume":"40","author":"Cotella JI","year":"2023","unstructured":"Cotella JI, Slivnick JA, Sanderson E, et al.. Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis. Echocardiography. 2023, 40:188-95. 10.1111\/echo.15516","journal-title":"Echocardiography"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112693","article-title":"A machine learning challenge: detection of cardiac amyloidosis based on bi-atrial and right ventricular strain and cardiac function","volume":"12","author":"Eckstein J","year":"2022","unstructured":"Eckstein J, Moghadasi N, K\u00f6rperich H, et al.. A machine learning challenge: detection of cardiac amyloidosis based on bi-atrial and right ventricular strain and cardiac function. Diagnostics (Basel). 2022, 12:2693. 10.3390\/diagnostics12112693","journal-title":"Diagnostics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.6059","article-title":"High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning","volume":"7","author":"Duffy G","year":"2022","unstructured":"Duffy G, Cheng PP, Yuan N, et al.. High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning. JAMA Cardiol. 2022, 7:386-95. 10.1001\/jamacardio.2021.6059","journal-title":"JAMA Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18030908","article-title":"Real-world data and machine learning to predict cardiac amyloidosis","volume":"18","author":"Garc\u00eda-Garc\u00eda E","year":"2021","unstructured":"Garc\u00eda-Garc\u00eda E, Gonz\u00e1lez-Romero GM, Mart\u00edn-P\u00e9rez EM, Zapata Cornejo ED, Escobar-Aguilar G, C\u00e1rdenas Bonnet MF. Real-world data and machine learning to predict cardiac amyloidosis. Int J Environ Res Public Health. 2021, 18:908. 10.3390\/ijerph18030908","journal-title":"Int J Environ Res Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121268","article-title":"Convolutional neural networks for fully automated diagnosis of cardiac amyloidosis by cardiac magnetic resonance imaging","volume":"11","author":"Agibetov A","year":"2021","unstructured":"Agibetov A, Kammerlander A, Duca F, et al.. Convolutional neural networks for fully automated diagnosis of cardiac amyloidosis by cardiac magnetic resonance imaging. J Pers Med. 2021, 11:1268. 10.3390\/jpm11121268","journal-title":"J Pers Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051334","article-title":"Machine learning enables prediction of cardiac amyloidosis by routine laboratory parameters: a proof-of-concept study","volume":"9","author":"Agibetov A","year":"2020","unstructured":"Agibetov A, Seirer B, Dachs TM, et al.. Machine learning enables prediction of cardiac amyloidosis by routine laboratory parameters: a proof-of-concept study. J Clin Med. 2020, 9:1334. 10.3390\/jcm9051334","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk RH","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol. 2016, 68:1323-41. 10.1016\/j.jacc.2016.06.053","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane T","year":"2019","unstructured":"Lane T, Fontana M, Martinez-Naharro A, et al.. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019, 140:16-26. 10.1161\/CIRCULATIONAHA.118.038169","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018, 18:s30-5. 10.7861\/clinmedicine.18-2-s30","journal-title":"Clin Med (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.14569\/IJACSA.2016.070218","article-title":"A framework for classifying unstructured data of cardiac patients: a supervised learning approach","volume":"7","author":"Basharat I","year":"2016","unstructured":"Basharat I, Anjum AR, Fatima M, Qamar U, Khan SA. A framework for classifying unstructured data of cardiac patients: a supervised learning approach. Int J Adv Comput Sci Appl. 2016, 7:10.14569\/IJACSA.2016.070218","journal-title":"Int J Adv Comput Sci Appl"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1609.01586","article-title":"A bootstrap machine learning approach to identify rare disease patients from electronic health records. [PREPRINT]","author":"Garg R","year":"2016","unstructured":"Garg R, Dong S, Shah S, Jonnalagadda SR. A bootstrap machine learning approach to identify rare disease patients from electronic health records. [PREPRINT]. arXiv. 2016, 10.48550\/arXiv.1609.01586","journal-title":"arXiv"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2022.12.006","article-title":"Clinical profile of patients with cardiac amyloidosis in India","volume":"75","author":"Mohan B","year":"2023","unstructured":"Mohan B, Singh S, Tandon R, et al.. Clinical profile of patients with cardiac amyloidosis in India. Indian Heart J. 2023, 75:73-6. 10.1016\/j.ihj.2022.12.006","journal-title":"Indian Heart J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters","volume":"10","author":"Pagourelias ED","year":"2017","unstructured":"Pagourelias ED, Mirea O, Duchenne J, et al.. Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters. Circ Cardiovasc Imaging. 2017, 10:e005588. 10.1161\/CIRCIMAGING.116.005588","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen OC","year":"2022","unstructured":"Cohen OC, Ismael A, Pawarova B, et al.. Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. Eur Heart J. 2022, 43:333-41. 10.1093\/eurheartj\/ehab507","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg FL","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:2872-91. 10.1016\/j.jacc.2019.04.003","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew130","article-title":"Amyloid in the heart: an under-recognized threat at the interface of cardiology, haematology, and pathology","volume":"17","author":"Bonderman D","year":"2016","unstructured":"Bonderman D, Agis H, Kain R, Mascherbauer J. Amyloid in the heart: an under-recognized threat at the interface of cardiology, haematology, and pathology. Eur Heart J Cardiovasc Imaging. 2016, 17:978-80. 10.1093\/ehjci\/jew130","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01781-z","article-title":"Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement","volume":"132","author":"Bonderman D","year":"2020","unstructured":"Bonderman D, P\u00f6lzl G, Ablasser K, et al.. Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement. Wien Klin Wochenschr. 2020, 132:742-61. 10.1007\/s00508-020-01781-z","journal-title":"Wien Klin Wochenschr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340685-the-role-of-artificial-intelligence-in-the-detection-of-cardiac-amyloidosis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T14:40:18Z","timestamp":1738680018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340685-the-role-of-artificial-intelligence-in-the-detection-of-cardiac-amyloidosis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.78488","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,4]]}}}